Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Breast Cancer

  Free Subscription


Articles published in Gene

Retrieve available abstracts of 33 articles:
HTML format
Text format



Single Articles


    November 2018
  1. LI J, Li B, Jiang Q, Zhang Y, et al
    Do genetic polymorphisms of the vitamin D receptor contribute to breast/ovarian cancer? A systematic review and network meta-analysis.
    Gene. 2018;677:211-227.
    PubMed     Text format     Abstract available


  2. ORANGI E, Motovali-Bashi M
    Evaluation of miRNA-9 and miRNA-34a as potential biomarkers for diagnosis of breast cancer in Iranian women.
    Gene. 2018;687:272-279.
    PubMed     Text format     Abstract available


    October 2018
  3. ZHOU J, Pei Y, Chen G, Cao C, et al
    SPC24 Regulates breast cancer progression by PI3K/AKT signaling.
    Gene. 2018;675:272-277.
    PubMed     Text format     Abstract available


  4. MA R, Zhai X, Zhu X, Zhang L, et al
    LINC01585 functions as a regulator of gene expression by the CAMP/CREB signaling pathway in breast cancer.
    Gene. 2018 Oct 23. pii: S0378-1119(18)31102-8. doi: 10.1016/j.gene.2018.
    PubMed     Text format     Abstract available


  5. JAHANGIRI R, Jamialahmadi K, Gharib M, Razavi AE, et al
    Expression and clinicopathological significance of DNA methyltransferase 1, 3A and 3B in tamoxifen-treated breast cancer patients.
    Gene. 2018 Oct 22. pii: S0378-1119(18)31099-0. doi: 10.1016/j.gene.2018.
    PubMed     Text format     Abstract available


  6. SHI S, Chen X, Liu H, Yu K, et al
    LGR5 acts as a target of miR-340-5p in the suppression of cell progression and drug resistance in breast cancer via Wnt/beta-catenin pathway.
    Gene. 2018 Oct 6. pii: S0378-1119(18)31039-4. doi: 10.1016/j.gene.2018.
    PubMed     Text format     Abstract available


    August 2018
  7. MAQBOOL SN, Nazeer HS, Rafiq M, Javed A, et al
    Bridging the gap by discerning SNPs in linkage disequilibrium and their role in breast cancer.
    Gene. 2018 Aug 14. pii: S0378-1119(18)30762-5. doi: 10.1016/j.gene.2018.
    PubMed     Text format     Abstract available


  8. JANAKI RAMAIAH M, Vaishnave S
    BMI1 and PTEN are key determinants of breast cancer therapy: A plausible therapeutic target in breast cancer.
    Gene. 2018 Aug 7. pii: S0378-1119(18)30872-2. doi: 10.1016/j.gene.2018.
    PubMed     Text format     Abstract available


    July 2018
  9. SHERAFATIAN M
    Tree-based machine learning algorithms identified minimal set of miRNA biomarkers for breast cancer diagnosis and molecular subtyping.
    Gene. 2018 Jul 25. pii: S0378-1119(18)30836-9. doi: 10.1016/j.gene.2018.
    PubMed     Text format     Abstract available


  10. SADAF, Habib M, Khan MA, Najm MZ, et al
    Hypermethylated LATS2 gene with decreased expression in female breast cancer: A case control study from North India.
    Gene. 2018 Jul 12. pii: S0378-1119(18)30807-2. doi: 10.1016/j.gene.2018.
    PubMed     Text format     Abstract available


  11. JIANG M, Xiao Y, Liu D, Luo N, et al
    Overexpression of long noncoding RNA LINC01296 indicates an unfavorable prognosis and promotes tumorigenesis in breast cancer.
    Gene. 2018 Jul 4. pii: S0378-1119(18)30773-X. doi: 10.1016/j.gene.2018.
    PubMed     Text format     Abstract available


    June 2018
  12. AL-OTHMAN N, Hammad H, Ahram M
    Dihydrotestosterone regulates expression of CD44 via miR-328-3p in triple-negative breast cancer cells.
    Gene. 2018 Jun 28. pii: S0378-1119(18)30755-8. doi: 10.1016/j.gene.2018.
    PubMed     Text format     Abstract available


  13. ULKER D, Ersoy YE, Gucin Z, Muslumanoglu M, et al
    Downregulation of SCARA5 may contribute to breast cancer via promoter hypermethylation.
    Gene. 2018 Jun 13. pii: S0378-1119(18)30687-5. doi: 10.1016/j.gene.2018.
    PubMed     Text format     Abstract available


  14. HESARI Z, Nourbakhsh M, Hosseinkhani S, Abdolvahabi Z, et al
    Down-regulation of NAMPT expression by mir-206 reduces cell survival of breast cancer cells.
    Gene. 2018 Jun 7. pii: S0378-1119(18)30672-3. doi: 10.1016/j.gene.2018.
    PubMed     Text format     Abstract available


    May 2018
  15. XU J, Zhang W, Tang L, Chen W, et al
    Epithelial-mesenchymal transition induced PAI-1 is associated with prognosis of triple-negative breast cancer patients.
    Gene. 2018 May 23. pii: S0378-1119(18)30586-9. doi: 10.1016/j.gene.2018.
    PubMed     Text format     Abstract available


  16. RAHMAN S, Zayed H
    Breast cancer in the GCC countries: A focus on BRCA1/2 and non-BRCA1/2 genes.
    Gene. 2018 May 16. pii: S0378-1119(18)30534-1. doi: 10.1016/j.gene.2018.
    PubMed     Text format     Abstract available


  17. BAGHI N, Bakhshinejad B, Keshavarz R, Babashah S, et al
    Dendrosomal nanocurcumin and exogenous p53 can act synergistically to elicit anticancer effects on breast cancer cells.
    Gene. 2018 May 10. pii: S0378-1119(18)30508-0. doi: 10.1016/j.gene.2018.
    PubMed     Text format     Abstract available


  18. REZAIE Z, Ardeshirylajimi A, Ashkezari MD
    Improved anticancer properties of stem cells derived exosomes by prolonged release from PCL nanofibrous structure.
    Gene. 2018 May 2. pii: S0378-1119(18)30480-3. doi: 10.1016/j.gene.2018.
    PubMed     Text format     Abstract available


    March 2018
  19. FEI HR, Li ZJ, Ying-Zhang, Yue-Liu, et al
    HBXIP regulates etoposide-induced cell cycle checkpoints and apoptosis in MCF-7 human breast carcinoma cells.
    Gene. 2018;647:39-47.
    PubMed     Text format     Abstract available


  20. RAGHAVAN S, Venkatraman G, Rayala SK
    Cloning and functional characterization of human Pak1 promoter by steroid hormones.
    Gene. 2018;646:120-128.
    PubMed     Text format     Abstract available


  21. XIAO B, Zhang W, Chen L, Hang J, et al
    Analysis of the miRNA-mRNA-lncRNA network in human estrogen receptor-positive and estrogen receptor-negative breast cancer based on TCGA data.
    Gene. 2018 Mar 5. pii: S0378-1119(18)30238-5. doi: 10.1016/j.gene.2018.
    PubMed     Text format     Abstract available


    February 2018
  22. HEYDARI N, Nikbakhsh N, Sadeghi F, Farnoush N, et al
    Overexpression of serum MicroRNA-140-3p in premenopausal women with newly diagnosed breast cancer.
    Gene. 2018 Feb 20. pii: S0378-1119(18)30167-7. doi: 10.1016/j.gene.2018.
    PubMed     Text format     Abstract available


  23. SINGH PK, Mistry K, Haritha C, Rank DN, et al
    Exploring the deleterious SNPs in XRCC4 gene using computational approach and studying their association with breast cancer in the population of West India.
    Gene. 2018 Feb 13. pii: S0378-1119(18)30176-8. doi: 10.1016/j.gene.2018.
    PubMed     Text format     Abstract available


  24. GHALI R, Al-Mutawa MA, Al-Ansari AK, Zaied S, et al
    Differential association of ESR1 and ESR2 gene variants with the risk of breast cancer and associated features: A case-control study.
    Gene. 2018 Feb 4. pii: S0378-1119(18)30140-9. doi: 10.1016/j.gene.2018.
    PubMed     Text format     Abstract available


  25. LI XP, Lan JY, Liu DQ, Zhou H, et al
    OCA2 rs4778137 polymorphism predicts survival of breast cancer patients receiving neoadjuvant chemotherapy.
    Gene. 2018 Feb 1. pii: S0378-1119(18)30121-5. doi: 10.1016/j.gene.2018.
    PubMed     Text format     Abstract available


    January 2018
  26. CHEN J, Jiang Y, Zhou J, Liu S, et al
    Evaluation of CpG-SNPs in miRNA promoters and risk of breast cancer.
    Gene. 2018 Jan 24. pii: S0378-1119(18)30085-4. doi: 10.1016/j.gene.2018.
    PubMed     Text format     Abstract available


  27. DANESH H, Hashemi M, Bizhani F, Hashemi SM, et al
    Association study of miR-100, miR-124-1, miR-218-2, miR-301b, miR-605, and miR-4293 polymorphisms and the risk of breast cancer in a sample of Iranian population.
    Gene. 2018 Jan 6. pii: S0378-1119(18)30032-5. doi: 10.1016/j.gene.2018.
    PubMed     Text format     Abstract available


    December 2017
  28. KAR S, Patra SK
    Overexpression of OCT4 induced by modulation of histone marks plays crucial role in breast cancer progression.
    Gene. 2017 Dec 1. pii: S0378-1119(17)31043-0. doi: 10.1016/j.gene.2017.
    PubMed     Text format     Abstract available


    November 2017
  29. KLASSEN LMB, Chequin A, Manica GCM, Biembengut IV, et al
    MMP9 gene expression regulation by intragenic epigenetic modifications in breast cancer.
    Gene. 2017 Nov 18. pii: S0378-1119(17)31018-1. doi: 10.1016/j.gene.2017.
    PubMed     Text format     Abstract available


  30. PENG R, Luo C, Guo Q, Cao J, et al
    Association analyses of genetic variants in long non-coding RNA MALAT1 with breast cancer susceptibility and mRNA expression of MALAT1 in Chinese Han population.
    Gene. 2017 Nov 13. pii: S0378-1119(17)30956-3. doi: 10.1016/j.gene.2017.
    PubMed     Text format     Abstract available


    October 2017
  31. JANAKI RAMAIAH M, Naushad SM, Lavanya PON, Gayatri A, et al
    Epigenetic regulation of miR-200 as the potential strategy for the therapy against triple-negative breast cancer.
    Gene. 2017 Oct 13. pii: S0378-1119(17)30831-4. doi: 10.1016/j.gene.2017.
    PubMed     Text format     Abstract available


  32. ZHOU L, Gao HF, Liu DS, Feng JY, et al
    Gene expression profiling of brain metastatic cell from triple negative breast cancer: Understanding the molecular events.
    Gene. 2017 Oct 9. pii: S0378-1119(17)30833-8. doi: 10.1016/j.gene.2017.
    PubMed     Text format     Abstract available


    September 2017
  33. LAHIRI DK, Maloney B, Sambamurti K
    When figures and data contradict text: MiR346 is apparently reduced in breast cancer tissue, contrary to claims by a paper's author.
    Gene. 2017 Sep 6. pii: S0378-1119(17)30646-7. doi: 10.1016/j.gene.2017.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Breast Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: